HKD 2.74
(-1.08%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 63.41 Billion | 61.94 Billion | 119.65 Billion | 113.23 Billion | 88.81 Billion |
Cost of Revenue | - | - | - | - | - |
Gross Profit | 63.41 Billion | 61.94 Billion | 119.65 Billion | 113.23 Billion | 88.81 Billion |
Operating Expenses | 63.41 Billion | -60.41 Billion | -117.33 Billion | -109.86 Billion | 83.29 Billion |
Selling, General and Administrative Expenses | 3.47 Billion | 2.91 Billion | 17.85 Billion | 21.5 Billion | 18.12 Billion |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 59.94 Billion | -63.33 Billion | -135.19 Billion | -131.37 Billion | - |
Cost and Expenses | 63.41 Billion | 54.89 Billion | 111.92 Billion | 106.39 Billion | 83.29 Billion |
Operating Income | - | 1.52 Billion | 2.31 Billion | 3.36 Billion | 5.62 Billion |
Interest Expense | 1.12 Billion | 998 Million | 1.34 Billion | 1.44 Billion | 1.3 Billion |
Income Tax Expense | 1.9 Billion | 177 Million | -295 Million | 737 Million | 59.01 Million |
Earnings before Tax | 5.77 Billion | 4.8 Billion | 5.72 Billion | 6.41 Billion | 4.47 Billion |
Net Income | 3.73 Billion | 4.49 Billion | 5.88 Billion | 5.61 Billion | 4.47 Billion |
Earnings Per Share Basic | 0.32 | 0.47 | 0.57 | 0.54 | 0.39 |
Earnings Per Share Diluted | 0.32 | 0.47 | 0.57 | 0.54 | 0.39 |
Weighted Average Shares Outstanding | 11.68 Billion | 10.42 Billion | 10.35 Billion | 10.4 Billion | 11.5 Billion |
Weighted Average Shares Outstanding (Diluted) | 11.5 Billion | 10.42 Billion | 10.35 Billion | 10.35 Billion | 11.5 Billion |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | 0.06 | 0.05 | 0.03 | 0.04 | -0.01 |
Profit Margin | 0.06 | 0.07 | 0.05 | 0.05 | 0.05 |
EBITDA | 3.69 Billion | 3.19 Billion | 4.05 Billion | 9.46 Billion | -1.08 Billion |
Earnings Before Tax Margin | - | 0.02 | 0.02 | 0.03 | 0.06 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 19.16 Billion | 19.16 Billion | 18.66 Billion | 63.41 Billion | 15.99 Billion | 20.02 Billion |
Cost of Revenue | - | - | 2.66 Billion | - | - | - |
Gross Profit | 19.16 Billion | 19.16 Billion | 15.99 Billion | 63.41 Billion | 15.99 Billion | 20.02 Billion |
Operating Expenses | 1.71 Billion | 1.71 Billion | 1.75 Billion | -61.42 Billion | 17.31 Billion | 15.25 Billion |
Selling, General and Administrative Expenses | 1.71 Billion | 1.71 Billion | 1.75 Billion | - | 1.75 Billion | 1.28 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | -64.89 Billion | - | - |
Cost and Expenses | 1.71 Billion | 1.71 Billion | 1.75 Billion | 55.47 Billion | 17.31 Billion | 15.25 Billion |
Operating Income | 17.45 Billion | 17.45 Billion | 16.9 Billion | 1.99 Billion | -1.32 Billion | 4.77 Billion |
Interest Expense | - | - | - | 1.11 Billion | - | - |
Income Tax Expense | 1.24 Billion | 1.24 Billion | 571.5 Million | 1.9 Billion | 571.5 Million | 382.5 Million |
Earnings before Tax | 2.85 Billion | 2.85 Billion | 1.02 Billion | 5.77 Billion | 1.02 Billion | 1.86 Billion |
Net Income | 1.57 Billion | 1.57 Billion | 421.5 Million | 3.73 Billion | 421.5 Million | 1.44 Billion |
Earnings Per Share Basic | 0.14 | 0.14 | 0.04 | - | 0.04 | 0.13 |
Earnings Per Share Diluted | 0.14 | 0.14 | 0.04 | - | 0.04 | 0.13 |
Weighted Average Shares Outstanding | 11.64 Billion | 11.64 Billion | 12.04 Billion | 11.68 Billion | 12.04 Billion | 11.58 Billion |
Weighted Average Shares Outstanding (Diluted) | 11.5 Billion | 11.5 Billion | 11.5 Billion | 11.5 Billion | 11.5 Billion | 11.5 Billion |
Gross Margin | 1.00 | 1.00 | 0.86 | 1.00 | 1.00 | 1.00 |
EBIT Margin | 0.91 | 0.91 | 0.12 | - | 0.14 | -0.15 |
Profit Margin | 0.08 | 0.08 | 0.02 | 0.06 | 0.03 | 0.07 |
EBITDA | 17.42 Billion | 17.42 Billion | 2.31 Billion | - | 2.31 Billion | -2.94 Billion |
Earnings Before Tax Margin | 0.91 | 0.91 | 0.91 | 0.03 | -0.08 | 0.24 |
HYEG
IFX
MEQ
BIOT
603188
GGRGF